Page last updated: 2024-08-24

cephalosporin c and Intra-Abdominal Infections

cephalosporin c has been researched along with Intra-Abdominal Infections in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	40 (81.63)	24.3611
2020's	9 (18.37)	2.80

Authors

Authors	Studies
Horcajada, JP; López Montesinos, I; Montero, M; Sorlí, L	1
Bensaci, M; Bruno, CJ; Chen, G; Chen, X; Du, X; Fan, J; Huntington, JA; Johnson, MG; Sun, F; Sun, Y; Wang, H; Wang, Y	1
Bensaci, M; Bruno, CJ; De Anda, C; Dementieva, N; Huntington, JA; Jackson, CA; Johnson, MG; Lonchar, J; Newland, J; Popejoy, MW; Rhee, EG; Su, FH	1
Ishizawa, T; Kimura, K; Kinoshita, M; Kubo, S; Nishio, K; Ohira, G; Okada, T; Shinkawa, H; Shirai, D; Tanaka, S; Tani, N; Tauchi, J	1
Bakthavatchalam, YD; Bano, N; Dubey, D; Dubey, M; Imran, A; Jain, B; Kulshrestha, V; Mitra, S; Roy, M; Sangwan, P; Shah, TH; Veeraraghavan, B; Velmurugan, A	1
Clancy, M; Stevens, RW	1
Cardoso, T; Silva-Nunes, J	1
Chen, YH; Cheng, IL; Lai, CC; Tang, HJ	1
Alimova, EE; Dibirov, MD; Isaev, AI; Karsotyan, GS; Khachatryan, NN; Kostyuk, EA	1
Baillon-Plot, N; Bassetti, M; Charbonneau, C; Di Virgilio, R; Eckmann, C; Kongnakorn, T; Tichy, E	1
Buonomo, AR; Gentile, I; Maraolo, AE; Mazzitelli, M; Torti, C; Trecarichi, EM	1
Alves, V; Cantón, R; Chaves, C; Diogo, J; Ferreira, R; García-Castillo, M; García-Fernández, S; Gonçalves, E; Melo-Cristino, J; Paixão, L; Pássaro, L; Pinto, MF; Ramalheira, E; Sancho, L; Silva, D; Vieira, AR	1
Collings, H; Dillon, R; Enstone, A; Palmer, T; Puzniak, L	1
Huntington, JA; Long, J; Popejoy, MW	1
Ahir, H; Foo, J; Merchant, S; Prabhu, V; Sarpong, E	1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Bassetti, M; De Rosa, FG; Del Bono, V; Giacobbe, DR; Grossi, PA; Menichetti, F; Pea, F; Rossolini, GM; Tumbarello, M; Viale, P; Viscoli, C	1
Caro, L; Huntington, JA; Long, J; Xiao, AJ	1
Ang, JY; Arrieta, AC; Bradley, JS; Caro, L; Johnson, MG; Larson, KB; Rhee, EG; Rizk, ML; Yang, S; Yu, B	1
Feng, HP; Kakara, M; Larson, K; Rizk, ML; Shiomi, M; Yoshitsugu, H	1
Fujimoto, G; Fukuhara, T; Horiuchi, T; Mikamo, H; Miyasaka, Y; Monden, K; Rhee, EG; Shizuya, T; Yoshinari, T	1
Bradley, JS; Caro, L; Larson, KB; Patel, YT; Rhee, EG; Rizk, ML; Willavize, S	1
Kim, B; Kim, J; Lee, MJ; Myung, R; Pai, H	1
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS	1
Friedland, I; Hershberger, E; Lucasti, C; Miller, B; Solomkin, J; Steenbergen, J; Yankelev, S	1
Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Ohge, H; Sudo, T; Sueda, T; Uemura, K	1
Aguilar, L; Gilsanz, F; Gimenez, MJ; Maseda, E	1
Eckmann, C; Solomkin, J	1
Barie, PS; Collins, S; Eckmann, C; Friedland, I; Hershberger, E; Miller, B; Popejoy, M; Solomkin, J; Steenbergen, J; Yoon, M; Yuan, G	1
Bassetti, M; Righi, E	1
Ahmed, S; Ali, SA; Arsalan, A; Naqvi, SB; Shakeel, O	1
Skalweit, MJ	1
Chahine, EB; Cogan, P; Fete, M; Sucher, AJ	1
Brass, EP; Spellberg, B	1
Eckmann, C; Hershberger, E; Solomkin, JS	1
Armstrong, ES; Farrell, DJ; Palchak, M; Steenbergen, JN	1
Hsu, AJ; Tamma, PD; Tamma, SM	1
Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M	1
Scott, LJ	1
Alverdy, J; Hershberger, E; Miller, B; Popejoy, MW; Steenbergen, JN	1
Borgia, G; Gentile, I; Maraolo, AE	1
Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O	1
Goldstein, EJ; Kullar, R; Long, J; Popejoy, MW; Wagenlehner, FM; Yu, B	1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF	1
Bassetti, M; Castanheira, M; Duncan, LR; Pfaller, MA	1
Adnan, S; Kumar, S; Li, J; Lipman, J; Paterson, DL; Roberts, JA; Rudd, M	1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW	1
Boĭko, VV; Ivanova, IuV	1

Reviews

12 review(s) available for cephalosporin c and Intra-Abdominal Infections

Article	Year
Ceftolozane-tazobactam: When, how and why using it? Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34 Suppl 1 Topics: Anti-Bacterial Agents; Cephalosporins; Colistin; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
The use of ceftolozane-tazobactam in the treatment of complicated intra-abdominal infections and complicated urinary tract infections-A meta-analysis of randomized controlled trials. International journal of antimicrobial agents, 2020, Volume: 55, Issue:2 Topics: Cephalosporins; Humans; Intraabdominal Infections; Randomized Controlled Trials as Topic; Tazobactam; Urinary Tract Infections	2020
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam; Urinary Tract Infections	2020
Real-world use of ceftolozane/tazobactam: a systematic literature review. Antimicrobial resistance and infection control, 2021, 04-08, Volume: 10, Issue:1 Topics: Cephalosporins; Comorbidity; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections	2021
Ceftolozane/tazobactam: place in therapy. Expert review of anti-infective therapy, 2018, Volume: 16, Issue:4 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Off-Label Use; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2018
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections. Expert review of anti-infective therapy, 2014, Volume: 12, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Combinations; Enzyme Inhibitors; Humans; Intraabdominal Infections; Penicillanic Acid; Tazobactam	2014
Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:2 Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Tazobactam	2015
Ceftolozane/Tazobactam (Zerbaxa)--a new intravenous antibiotic. The Medical letter on drugs and therapeutics, 2015, Mar-02, Volume: 57, Issue:1463 Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; Cephalosporins; Clinical Trials as Topic; Humans; Intraabdominal Infections; Penicillanic Acid; Tazobactam; Urinary Tract Infections	2015
Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections. Drug design, development and therapy, 2015, Volume: 9 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Humans; Intraabdominal Infections; Penicillanic Acid; Tazobactam; United States; United States Food and Drug Administration	2015
Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination. The Annals of pharmacotherapy, 2015, Volume: 49, Issue:9 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Humans; Intraabdominal Infections; Mice; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2015
Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections. Drugs, 2016, Volume: 76, Issue:2 Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Humans; Intraabdominal Infections; Multicenter Studies as Topic; Penicillanic Acid; Tazobactam; Urinary Tract Infections	2016
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review. Surgical infections, 2012, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Diffusion; Drainage; Humans; Intraabdominal Infections; Metabolic Clearance Rate; Penicillins	2012

Trials

12 trial(s) available for cephalosporin c and Intra-Abdominal Infections

Article	Year
A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 123 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; China; Double-Blind Method; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Tazobactam	2022
Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection. The Pediatric infectious disease journal, 2023, Jul-01, Volume: 42, Issue:7 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Escherichia coli; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Penicillanic Acid; Tazobactam	2023
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam. BMC infectious diseases, 2017, 05-02, Volume: 17, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections	2017
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:11 Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Intraabdominal Infections; Male; Tazobactam; Urinary Tract Infections	2018
Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Cephalosporins; Female; Humans; Intraabdominal Infections; Japan; Male; Middle Aged; Models, Statistical; Tazobactam; Urinary Tract Infections; Young Adult	2019
The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteria; Cephalosporins; Female; Humans; Intraabdominal Infections; Japan; Male; Metronidazole; Middle Aged; Tazobactam; Treatment Outcome	2019
Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intraabdominal Infections; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome	2014
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, May-15, Volume: 60, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Penicillanic Acid; Prospective Studies; Tazobactam; Treatment Outcome; Young Adult	2015
In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Cephalosporins; Drug Therapy, Combination; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam	2016
Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam	2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:1 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult	2017
Does moderate renal impairment affect clinical outcomes in complicated intra-abdominal and complicated urinary tract infections? Analysis of two randomized controlled trials with ceftolozane/tazobactam. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Penicillanic Acid; Renal Insufficiency; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult	2017

Other Studies

25 other study(ies) available for cephalosporin c and Intra-Abdominal Infections

Article	Year
Efficacy and safety of tazobactam/ceftolozane in combination with metronidazole for intraabdominal infection in a hepato-biliary-pancreatic field in clinical practice. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:9 Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Intraabdominal Infections; Metronidazole; Penicillanic Acid; Tazobactam	2023
Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis p Annals of clinical microbiology and antimicrobials, 2023, Jul-05, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Compassionate Use Trials; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Monobactams; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis	2023
Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug-Resistant Pseudomonas aeruginosa: A Case Report. Pharmacotherapy, 2019, Volume: 39, Issue:11 Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Compassionate Use Trials; Drug Resistance, Multiple, Bacterial; Humans; Intraabdominal Infections; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2019
Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment. BMC infectious diseases, 2019, Nov-21, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Retrospective Studies	2019
[New possibilities in antibacterial treatment of intra-abdominal infections caused by multiresistant microflora]. Khirurgiia, 2019, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Intraabdominal Infections; Penicillanic Acid	2019
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI). Antimicrobial resistance and infection control, 2019, Volume: 8 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftazidime; Cephalosporins; Cost-Benefit Analysis; Drug Combinations; Hospitalization; Humans; Intraabdominal Infections; Italy; Meropenem; Models, Economic; Tazobactam	2019
In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: The STEP multicenter study. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Intraabdominal Infections; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections	2020
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK. Journal of medical economics, 2017, Volume: 20, Issue:8 Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cephalosporins; Clinical Protocols; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Male; Metronidazole; Models, Econometric; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Tazobactam; United Kingdom	2017
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2017
Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection. International journal of antimicrobial agents, 2018, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Obesity, Morbid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2018
Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated Intra-abdominal Infections. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Tazobactam; Urinary Tract Infections; Young Adult	2019
Trend of antibiotics usage for acute pyelonephritis in Korea based on national health insurance data 2010-2014. BMC infectious diseases, 2019, Jun-25, Volume: 19, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; Cephalosporins; Databases, Factual; Drug Utilization; Female; Fluoroquinolones; Humans; Insurance Claim Review; Intraabdominal Infections; Male; Middle Aged; National Health Programs; Practice Patterns, Physicians'; Pyelonephritis; Republic of Korea; Young Adult	2019
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012). The Journal of infection, 2014, Volume: 69, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacter; Escherichia coli; Europe; Gram-Negative Aerobic Bacteria; Humans; Intraabdominal Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Proteus mirabilis; Pseudomonas aeruginosa; Serratia; Tazobactam; United States; Urinary Tract Infections	2014
Perioperative antibiotics covering bile contamination prevent abdominal infectious complications after pancreatoduodenectomy in patients with preoperative biliary drainage. World journal of surgery, 2014, Volume: 38, Issue:11 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bile; Cefazolin; Cefozopran; Cephalosporins; Colony Count, Microbial; Drainage; Female; Humans; Intraabdominal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Pancreaticoduodenectomy; Preoperative Care; Prospective Studies	2014
Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections. Future microbiology, 2015, Volume: 10, Issue:2 Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Investigational New Drug Application; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome; Urinary Tract Infections	2015
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi. Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan; Proteus; Proteus Infections; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections	2015
Noninferiority Doesn't Mean Not Inferior. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Feb-15, Volume: 62, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Penicillanic Acid	2016
Response to Spellberg and Brass. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Feb-15, Volume: 62, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Penicillanic Acid	2016
Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications. Paediatric drugs, 2016, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; Cephalosporins; Child; Humans; Intraabdominal Infections; Penicillanic Acid; Tazobactam	2016
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013]. Zhonghua yi xue za zhi, 2015, Jun-09, Volume: 95, Issue:22 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin	2015
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam? Expert review of anti-infective therapy, 2016, Volume: 14, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Journal of medical microbiology, 2017, Volume: 66, Issue:1 Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections	2017
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15). The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Europe; Humans; Intraabdominal Infections; Israel; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Turkey; Urinary Tract Infections	2017
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies	2012
[Enhancing efficacy of the primary antibacterial therapy for intraabdominal infections]. Klinichna khirurhiia, 2012, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Digestive System Surgical Procedures; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Male; Middle Aged; Nitroimidazoles; Peritoneal Cavity; Ukraine	2012